Net revenue for the quarter ended Sept. 26 totaled $309.4 million, up from $283.8 million last year. The Street's view was for $296.9 million.
The company maintained its guidance for fiscal 2022, including total revenue growth of 10% to 12% and adjusted earnings before interest, taxes, depreciation and amortization growth of 5% to 8%.
The company's shares were 2% higher in recent premarket activity.
Price: 29.09, Change: +0.57, Percent Change: +2.00
|Macquarie Adjusts Sea's Price Target to $285 From $4...|
|Sellas Life Sciences Receives Regulatory Clearance f...|
|HSBC Lifts Albemarle to Buy From Hold, Price Target ...|
|--JMP Securities Downgrades Cortexyme to Market Perf...|
|Pretium Resources Secures British Columbia Court App...|